HURRICANE CAPITAL ADVISORS LLC’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Hold
13,350
– – 0.08% 255
2026
Q1
$375K Buy
13,350
+8,000
+150% +$213K 0.12% 155
2025
Q4
$133K Hold
5,350
– – 0.04% 361
2025
Q3
$136K Hold
5,350
– – 0.03% 385
2025
Q2
$130K Sell
5,350
-6,000
-53% -$140K 0.03% 334
2025
Q1
$288K Buy
11,350
+500
+5% +$13.1K 0.1% 160
2024
Q4
$288K Sell
10,850
-1,650
-13% -$44.8K 0.08% 171
2024
Q3
$362K Sell
12,500
-600
-5% -$17.5K 0.13% 129
2024
Q2
$367K Buy
13,100
+6,500
+98% +$179K 0.13% 120
2024
Q1
$183K Buy
6,600
+702
+12% +$19.5K 0.05% 240
2023
Q4
$170K Buy
+5,898
New +$178K 0.07% 183

Other funds holding PFE

HURRICANE CAPITAL ADVISORS LLC's PFE Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC held its Pfizer (PFE) position steady in Q2 2026 at 13,350 shares worth $321K. The position accounts for 0.08% of the portfolio, ranked #255.

HURRICANE CAPITAL ADVISORS LLC first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $375K in Q1 2026. 2,854 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 13,350 shares of Pfizer worth $321K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.08% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #255 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's Pfizer position peaked at $375K in Q1 2026.
  • 2,854 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.